{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:56:32Z","timestamp":1790571392281,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myocardial infarction (MI) remains a leading cause of mortality worldwide. Although current reperfusion-based interventions have significantly improved clinical outcomes, they are insufficient to restore lost cardiomyocytes or repair irreversible myocardial injury. Programmable messenger RNA (mRNA)-based therapeutics have emerged as a cutting-edge strategy for cardiac regenerative repair owing to their advantages of transient and controllable protein expression, high design flexibility, and avoidance of genomic integration. However, the global research landscape, collaborative networks, and evolving scientific priorities in this rapidly expanding field have not yet been systematically characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive bibliometric analysis was conducted using publications retrieved from the Web of Science Core Collection (WoSCC) and PubMed databases from 2012 to 2026. After literature screening and deduplication, 814 publications from WoSCC and 4,155 publications from PubMed were included. VOSviewer, CiteSpace, and the R package Bibliometrix were used to conduct parallel analyses of annual publication trends, country- and institutional-collaboration networks, journal and author distributions, reference citation bursts, and keyword-based thematic evolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>WoSCC analysis revealed a fluctuating but overall increasing publication trajectory, with annual research output peaking at \u223c90 publications in 2023. The evolution of this field could be categorized into three stages: an emerging phase (2012\u20132016), a developmental phase (2017\u20132021), and an accelerated expansion phase (2022 onward). China and the United States represented the leading contributors, while institutions including Harvard University and the Chinese Academy of Medical Sciences-Peking Union Medical College served as major research hubs. Circulation Research and Circulation occupied central positions within the co-citation network. ZANG, LICHUN was identified as the most productive author, whereas the landmark 2013 study by Zangi L represented the most influential foundational contribution to the field. Parallel analysis of PubMed further validated the identified evolutionary trends and highlighted angiogenesis as a promising yet underexplored research direction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Research on programmable mRNA therapeutics for MI is rapidly expanding, with the focus shifting from fundamental molecular mechanisms to translational applications that enable precise inflammatory modulation, fibrosis reversal, and revascularization. Future breakthroughs will likely depend on the development of efficient and cardiac-targeted delivery platforms, as well as deeper exploration of epitranscriptomic therapeutic strategies, to accelerate clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1957977","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:29:44Z","timestamp":1790569784000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global landscape and emerging trends in programmable mRNA-based therapeutics for myocardial infarction: a multi-database bibliometric analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ying-liang","family":"Zhang","sequence":"first","affiliation":[{"name":"Graduate School, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-yi","family":"Liu","sequence":"additional","affiliation":[{"name":"Second Clinical Medical College, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-chen","family":"Meng","sequence":"additional","affiliation":[{"name":"Graduate School, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-tong","family":"Zhou","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-zheng","family":"Xu","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-ling","family":"Ma","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ge","family":"Chen","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Graduate School, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-chi","family":"Zhu","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Dong","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-hao","family":"Zhang","sequence":"additional","affiliation":[{"name":"First Clinical Medical College, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-yan","family":"Fan","sequence":"additional","affiliation":[{"name":"Second Clinical Medical College, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-zhu","family":"Liu","sequence":"additional","affiliation":[{"name":"Graduate School, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-you","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11427-024-2967-8","article-title":"Decoding noncoding RNAs in regulating cardiovascular aging and age-related conditions: the emerging landscape","volume":"69","author":"Wang","year":"2026","journal-title":"Sci China Life Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"20417314221088509","DOI":"10.1177\/20417314221088509","article-title":"Recent advance in treatment of atherosclerosis: key targets and plaque-positioned delivery strategies","volume":"13","author":"Li","year":"2022","journal-title":"J Tissue Eng"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e015043","DOI":"10.1136\/bmjgh-2024-015043","article-title":"The economic burden of ischaemic heart diseases on health systems: a systematic review","volume":"10","author":"Rittiphairoj","year":"2025","journal-title":"BMJ Glob Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3390\/jcm15072603","article-title":"Myocardial infarction as the first clinical manifestation of coronary artery disease: a scoping review","volume":"15","author":"D'Angelo","year":"2026","journal-title":"J Clin Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13020-025-01299-4","article-title":"Yixinshu attenuates myocardial infarction via SHP1\/JAK2\/STAT3-mediated regulation of mitochondrial function and apoptosis","volume":"21","author":"Wang","year":"2026","journal-title":"Chin Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.yjmcc.2015.12.018","article-title":"Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling","volume":"91","author":"Lindsey","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/CP9.0000000000000140","article-title":"Incident heart failure and related outcomes in survivors of acute myocardial infarction within the first year in Sweden across 25 years, between 1997 and 2022","volume":"10","author":"Fu","year":"2025","journal-title":"Cardiol Plus"},{"key":"B9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.jacasi.2024.07.012","article-title":"Translational research and clinical application of traditional Chinese medicine in cardiovascular diseases","volume":"4","author":"Cheang","year":"2024","journal-title":"JACC Asia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7493","DOI":"10.2147\/JIR.S512050","article-title":"Integrating network pharmacology and in vivo validation to explore the mechanisms of Buyang Huanwu decoction in myocardial ischemia-reperfusion injury","volume":"18","author":"Luo","year":"2025","journal-title":"J Inflamm Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"T39","DOI":"10.4244\/EIJV10STA8","article-title":"Primary PCI: time to change focus from epicardial reperfusion towards protection of the microvasculature","volume":"10","author":"Van Lavieren","year":"2014","journal-title":"EuroIntervention"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/cvr\/cvy286","article-title":"The coronary circulation in acute myocardial ischaemia\/reperfusion injury: a target for cardioprotection","volume":"115","author":"Hausenloy","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/cvr\/cvae207","article-title":"Gene therapy for cardiac diseases: methods, challenges, and future directions","volume":"120","author":"Grisorio","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e471","DOI":"10.1161\/CIR.0000000000001296","article-title":"Gene therapy in cardiovascular disease: recent advances and future directions in science: a science advisory from the American heart association","volume":"150","author":"Kim","year":"2024","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100143","DOI":"10.1016\/j.celbio.2025.100143","article-title":"Biomimetic artificial enveloped viral vectors: overcoming immune barriers for re-administration and long-term gene therapy","volume":"1","author":"Pan","year":"2025","journal-title":"Cell Biomater"},{"key":"B16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00109-022-02208-0","article-title":"Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective","volume":"100","author":"Schwartze","year":"2022","journal-title":"J Mol Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ymthe.2017.03.016","article-title":"Optimizing cardiac delivery of modified mRNA","volume":"25","author":"Sultana","year":"2017","journal-title":"Mol Ther"},{"key":"B18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4939-6588-5_8","article-title":"Synthesis of modified mRNA for myocardial delivery","volume-title":"Cardiac Gene Therapy: Methods and Protocols","author":"Kondrat","year":"2017"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1021\/acs.jcim.5c02871","article-title":"Accelerating siloxane-based ionizable lipid design for LNPs with data-efficient Kolmogorov-Arnold networks","volume":"66","author":"Zhao","year":"2026","journal-title":"J Chem Inf Model"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e037120","DOI":"10.1161\/JAHA.124.037120","article-title":"Cardiomyocyte-specific overexpression of activated yes-associated protein modified-RNA promotes cardiomyocyte proliferation and myocardial regeneration","volume":"13","author":"Wang","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1707654","DOI":"10.3389\/fimmu.2025.1707654","article-title":"mRNA vaccines transform personalized lung cancer treatment","volume":"16","author":"Wei","year":"2026","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e2206187","DOI":"10.1002\/advs.202206187","article-title":"Lipid nanoparticles deliver the therapeutic VEGFA mRNA in vitro and in vivo and transform extracellular vesicles for their functional extensions","volume":"10","author":"Nawaz","year":"2023","journal-title":"Adv Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtn.2018.08.021","article-title":"Ablation of a single N-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration","volume":"13","author":"Magadum","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"B24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature15372","article-title":"Epicardial FSTL1 reconstitution regenerates the adult mammalian heart","volume":"525","author":"Wei","year":"2015","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s44161-026-00804-8","article-title":"mRNA medicine for cardiovascular disease","volume":"5","author":"Zhou","year":"2026","journal-title":"Nat Cardiovasc Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e4354","DOI":"10.7717\/peerj.4354","article-title":"A bibliometric analysis in gene research of myocardial infarction from 2001 to 2015","volume":"6","author":"Zhou","year":"2018","journal-title":"PeerJ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40001-022-00967-7","article-title":"Insights into research on myocardial ischemia\/reperfusion injury from 2012 to 2021: a bibliometric analysis","volume":"28","author":"Bai","year":"2023","journal-title":"Eur J Med Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e41368","DOI":"10.1097\/MD.0000000000041368","article-title":"Mapping the knowledge of omics in myocardial infarction: a scientometric analysis in R studio, VOSviewer, citespace, and SciMAT","volume":"104","author":"Wei","year":"2025","journal-title":"Medicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","article-title":"How to conduct a bibliometric analysis: an overview and guidelines","volume":"133","author":"Donthu","year":"2021","journal-title":"J Bus Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1834916","DOI":"10.3389\/fmed.2026.1834916","article-title":"Associations between prevalent unhealthy lifestyles and the gut microbiota: a comprehensive multi-database bibliometric analysis of pathogenic mechanisms and clinical trajectories","volume":"13","author":"Zhou","year":"2026","journal-title":"Front Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1037051","DOI":"10.3389\/fbioe.2022.1037051","article-title":"mRNA therapy for myocardial infarction: a review of targets and delivery vehicles","volume":"10","author":"Wang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3390\/ijms26010231","article-title":"Innovative therapeutic strategies for myocardial infarction across various stages: non-coding RNA and stem cells","volume":"26","author":"Zhuang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1873905","DOI":"10.3389\/fimmu.2026.1873905","article-title":"In vivo immune engineering via mRNA therapeutics: reprogramming the post-infarction cardiac microenvironment","volume":"17","author":"Liu","year":"2026","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1426583","DOI":"10.3389\/fcvm.2025.1426583","article-title":"Angiogenesis after acute myocardial infarction: a bibliometric -based literature review","volume":"12","author":"Tan","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.omtn.2022.06.007","article-title":"Angiogenesis: a critical determinant for cardiac regeneration","volume":"29","author":"Singh","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"B39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s11596-017-1766-0","article-title":"Hypoxia enhances the therapeutic potential of superparamagnetic iron oxide-labeled adipose-derived stem cells for myocardial infarction","volume":"37","author":"Wang","year":"2017","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41434-022-00322-9","article-title":"AAV2-VEGF-B gene therapy failed to induce angiogenesis in ischemic porcine myocardium due to inflammatory responses","volume":"29","author":"Korpela","year":"2022","journal-title":"Gene Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1669362","DOI":"10.3389\/fcvm.2025.1669362","article-title":"Targeting the notch signaling pathway: molecular mechanisms and therapeutic strategies for cardiac repair after myocardial infarction","volume":"12","author":"Zhang","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e202500521","DOI":"10.1002\/smsc.202500521","article-title":"Nanomicelle-based multi-mRNA delivery promotes cardiac repair after myocardial infarction","volume":"6","author":"Handa","year":"2026","journal-title":"Small Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41440-019-0338-z","article-title":"N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases","volume":"43","author":"Paramasivam","year":"2020","journal-title":"Hypertens Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10565-025-10039-1","article-title":"METTL3-mediated M6a methylation in cardiac diseases: pathogenic roles and therapeutic potential","volume":"41","author":"Liu","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e2529187123","DOI":"10.1073\/pnas.2529187123","article-title":"METTL3-mediated N6-methyladenosine modification of Dnajb1 modulates cardiomyocyte ferroptosis during myocardial infarction","volume":"123","author":"Zhang","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1042\/BST20243001","article-title":"Using modified mRNA for cardiomyocyte proliferation and cardiac genetic disease modelling and treatment","volume":"53","author":"Batho","year":"2025","journal-title":"Biochem Soc Trans"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1021\/acs.chemrev.5c00347","article-title":"Beyond the sequence: chemical and topological design and innovations in mRNA therapeutics","volume":"126","author":"Liu","year":"2026","journal-title":"Chem Rev"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1957977\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:29:46Z","timestamp":1790569786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1957977\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":48,"alternative-id":["10.3389\/fmed.2026.1957977"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1957977","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1957977"}}